万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/1872034x
3、投稿网址：
http://mc.manuscriptcentral.com/hepres
4、官网邮箱：hapatologyresearch@Wiley.com
5、官网电话：81 3 3830 1267
6、期刊刊期：月刊，一年出版12期。
2021年5月27日星期四
投稿须知【官网信息】
Author Guidelines
AIMS AND SCOPE
Hepatology Research (formerly International Hepatology Communications) is the official journal of the Japan Society of Hepatology, and publishes original articles, reviews and short communications dealing with hepatology. Reviews or mini-reviews are especially welcomed from those areas within hepatology undergoing rapid changes.
EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Please submit, with the manuscript, the names and addresses of three potential referees. You may also mention persons who you would prefer not to review your paper. The choice of reviewers remains the Editor’s prerogative.
Manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision.
Revised manuscripts should be returned to the Editorial Office within 60 days for minor revision or 120 days major revision. After this period, the article will be regarded as a new submission and assigned a new date of receipt.
It is the policy of this journal that the Editor’s decision on manuscripts submitted to Hepatology Research is final. Resubmitted manuscripts after a reject decision will not be considered.
ELECTRONIC SUBMISSION OF MANUSCRIPTS
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/hepres. Authors must supply an email address as all correspondence will be by email. Two files should be supplied: the covering letter and the manuscript (in Word or rich text format (.rtf)). The covering letter should be uploaded as a file not for review. Use of the online system, ScholarOne Manuscripts, speeds up the review process, improves accuracy, enables immediate distribution of files, and allows authors to track their own manuscripts. If you have any problems using the system, please contact ScholarOne Manuscripts technical support, Clarivate Analytics. (http://mchelp.manuscriptcentral.com/gethelpnow/).
For authors unable to submit their manuscript online, please consult Hepatology Research Editorial Office.
All articles submitted to the Journal must comply with these instructions. Failure to do so will result in return of the manuscript and possible delay in publication.
• Submissions should be double-spaced.
• All margins should be at least 30 mm.
• All pages should be numbered consecutively in the top right-hand corner, beginning with the title page.
• Do not use Enter at the end of lines within a paragraph.
• Turn the hyphenation option off; include only those hyphens that are essential to the meaning.
• Specify any special characters used to represent non-keyboard characters.
• Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for Greek beta.
• Use a tab, not spaces, to separate data points in tables. If you use a table editor function, ensure that each data point is contained within a unique cell (i.e. do not use carriage returns within cells).
Each figure should be supplied as a separate file, with the figure number incorporated in the file name. Files saved as .ppt are not acceptable at any stage. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files should be uploaded. Digital images supplied only as low-resolution files cannot be used.
Further instructions are available at the submission site.
Covering letter
Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium. This must be stated in the covering letter.
The covering letter must also contain an acknowledgment that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.
If tables or figures have been reproduced from another source, a letter from the copyright holder (usually the Publisher), stating authorization to reproduce the material, must be attached to the covering letter.
Declaration of Conflict of Interest
Authors must declare any financial support or relationships that may pose conflict of interest in the covering letter by submitting their manuscript online. Please refer to the Policy of the Japan Society of Hepatology regarding Conflicts of Interest and the Bylaws of Conflict of Interest in Clinical Research.
Author material archive policy
Authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Wiley will dispose of all hardcopy and electronic material two months after publication.
ETHICAL CONSIDERATIONS
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki available at https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/.
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
Data Sharing and Data Accessibility
The Journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors may provide a data availability statement, including a link to the repository they have used, in order that this statement can be published in their paper. Shared data should be cited. Please also review Wiley’s policy here.
COPYRIGHT, LICENSING and ONLINE OPEN
Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper.
FAQs about the terms and conditions of the standard copyright transfer agreements (CTA) in place for the journal, including terms regarding archiving of the accepted version of the paper, are available at: CTA Terms and Conditions FAQs
OnlineOpen – ‘Gold road’ Open Access
OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons licence. In addition, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access, known as ‘gold road’ open access.
OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND).
For more information about the OnlineOpen license terms and conditions click here.
STYLE OF THE MANUSCRIPT
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/.
Spelling. The Journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.
Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
Abbreviations. Abbreviations should be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Chemical substances should be referred to by the generic name only. Trade names should not used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.’
Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
GenBank http://www.ncbi.nlm.nih.gov
PARTS OF THE MANUSCRIPT
The journal publishes papers dealing with hepatology in the following categories (word limits include text and references, but not tables or figures). Case reports will be accepted only if they contain very important new information.
• Review Article: Up to 5,000 words (including References) and a maximum of 4 authors. The number of tables/figures is not limited.
• Original Article: Up to 4,000 words (excluding References). The number of tables/figures is not limited.
• Short Communication: Up to 2,000 words (excluding References) and up to four tables/figures in total.
• Case Report: Up to 2,000 words (excluding References) and up to four tables/figures in total.
• Letter to the Editor: Up to 500 words and up to 10 references with one table/figure in total; no abstract.
• Editorial: Up to 1,500 words (including References) and a maximum of 1 author only; no abstract.
Manuscripts should be presented in the following order: (i) title page, (ii) abstract and key words, (iii) text, (iv) acknowledgments, (v) references, (vi) appendices, (vii) figure legends, (viii) tables (each table complete with title and footnotes) and (ix) figures. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page
The title page should contain (i) the title of the paper, (ii) the full names of the authors and (iii) the addresses of the institutions at which the work was carried out together with (iv) the full postal and email address, plus facsimile and telephone numbers, of the author to whom correspondence about the manuscript should be sent. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
The title should be short, informative and contain the major key words. Do not use abbreviations in the title. A short running title (less than 50 characters including spaces) should also be provided.
Abstract and key words
All articles must have a structured abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Aim, Methods, Results, Conclusions.
A maximum of six key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.
Text
Authors should use the following subheadings to divide the sections of their manuscript: Introduction, Methods, Results and Discussion.
Acknowledgments
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
References
The Vancouver system of referencing should be used (examples are given below). Review your reference style guidelines prior to submission. In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text.
We recommend the use of a tool such as Reference Manager for reference management and formatting. Reference Manager reference styles can be searched for here:
http://www.refman.com/support/rmstyles.asp
In the reference list, cite the names of all authors when there are six or fewer; when seven or more, list the first six followed by et al. Do not use ibid. or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list.
Names of journals should be abbreviated according to the Serial Sources for the Biosis Data Base, available in most libraries or from http://www.biosis.org.
Authors are responsible for the accuracy of the references.
Journal article
1 Tanaka T, Lau JYN, Mizokami M,E Orito, E Tanaka, K Kiyosawa, et al. Simple fluroesent EIA for detection and quantification of hepatitis C viremia. J Hepatol 1995; 23: 78–9.
Journal articles published ahead of issue (print or online)
2 Benz PJ, Soll J, Bölter B. Protein transport in organelles: The composition, function and regulation of the Tic complex in chloroplast protein import. FEBS Journal, 2009. doi: 10.1111/j.1742-4658.2009.06874.x
World Wide Web
3 Centers for Medicare & Medicaid Services. Preparing for Emergencies: A Guide for People on Dialysis. Available at: http://www.medicare.gov/Publications/Pubs/pdf/10150.pdf. Accessed January 13, 2004.
Book
4 Lehninger AD. Principles of Biochemistry. New York: Worth Publishers, 2000.
Chapter in a Book
5 Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd edn. New York: Raven Press, 1995; 465–78.
Appendices
These should be placed at the end of the paper, numbered in Roman numerals and referred to in the text. If written by a person other than the author of the main text, the writer’s name should be included below the title. Extensive sets of data, such as large tables or long appendices, may be classed as Supplementary Material. Author guidelines for supplementary material can be found at http://authorservices.wiley.com/bauthor/suppmat.asp
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Figures should be sized to fit within the column (80.5 mm), intermediate (110 mm) or the full text width (168 mm). Magnifications should be indicated using a scale bar on the illustration.
Line figures should be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package. Lettering must be included and should be sized to be no larger than the journal text.
Colour figures may be published online free of charge; however, the journal charges for publishing figures in colour in print. If the author supplies colour figures at Early View publication, they will be invited to complete a colour charge agreement in RightsLink for Author Services. The author will have the option of paying immediately with a credit or debit card, or they can request an invoice. If the author chooses not to purchase colour printing, the figures will be converted to black and white for the print issue of the journal.
PROOFS
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.
Substantial changes in content, e.g., new results, corrected values, and title, are not allowed without the approval of the Editor.
After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.
OFFPRINTS
A free PDF offprint will be supplied to the corresponding author. A minimum of 25 additional offprints will be provided upon request, at the author’s expense. These paper offprints may be ordered online. Please visit www.sheridan.com/wiley/eoc, fill in the necessary details and ensure that you type information in all of the required fields.
ACCEPTED ARTICLES
Hepatology Researchoffers Accepted Articles for selected articles. Accepted Articles is a Wiley service whereby peer-reviewed accepted articles are published online prior to their ultimate inclusion in a print or online issue. Articles published within Accepted Articles have been fully refereed, but have not been through the copy-editing, typesetting and proof correction process.
EARLY VIEW
Hepatology Research is covered by Wiley’s EarlyView service. EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. EarlyView articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors’ final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of EarlyView articles means that they do not yet have volume, issue or page numbers, so EarlyView articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html.
WILEY JOURNALS ONLINE
Visit the Hepatology Research home page at wileyonlinelibrary.com/journal/hepr for more information, and Wiley’s web pages for submission guidelines and digital graphics standards. Hepatology Research is also available online via Wiley Online Library at http://wileyonlinelibrary.com.
EDITORIAL OFFICE ADDRESS
Editorial Office, Hepatology Research
c/o Wiley Publishing Japan
Koishikawa Sakura Bldg., 4F
1-28-1 Koishikawa, Bunkyo-ku
Tokyo 112-0002 Japan
E-mail: hepatologyresearch@wiley.com
Tel: 81 3 3830 1267
Fax: 81 3 5689 7278
